Publication | Open Access
The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
39
Citations
39
References
2016
Year
Molecular PharmacologyHypertensionMetabolic SyndromeExperimental Diabetes-associated AtherosclerosisCardiovascular DiseaseVascular PharmacologyPhysiologyPharmacologyDiabetesDiabetic Kidney DiseaseVascular BiologyMicrovascular DysfunctionMedicineAtherosclerosisHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1